All tenders
75F40126C00055

BAA FY26C1FP7; MD ANDERSON; ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS

Department of Health and Human Services · TX, United States

This contract has been awarded. Browse open opportunities
View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number
75F40126C00055
Government level
Federal
Solicitation type
Other
Title
BAA FY26C1FP7; MD ANDERSON; ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS
Source ID
CONT_AWD_75F40126C00055_7524_-NONE-_-NONE-

Details

Location
TX, United States

Description

BAA FY26C1FP7; MD ANDERSON; ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS Awarded to: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Sub-agency: Food and Drug Administration Contract type: DEFINITIVE CONTRACT

Dates

Publication
2026/09/30 12:00:00 AM UTC
Closing date
2028/09/29 12:00:00 AM UTC

Estimated value

$752K USD

Classification

Normalized category

Other

Source: usaspending

Last updated 2026-09-02, 12:03:33 p.m.

Data refreshed every 2 hours